IMII-US T.B.1-3 EOD
IMII-US T.B.1-3 EOD
ETF · IE00BF2FNJ76 · A3E4ZY (XFRA)
Overview
No Price
Closing Price XFRA 27.01.2026: 35,25 EUR
27.01.2026 09:26
Current Prices from IMII-US T.B.1-3 EOD
ExchangeTickerCurrencyLast TradePriceDaily Change
XFRA: Frankfurt
Frankfurt
T3RE.F
EUR
27.01.2026 09:26
35,25 EUR
0,32 EUR
+0,92 %
XDQU: Quotrix
Quotrix
IMI2US76.DUSD
EUR
27.01.2026 06:27
35,27 EUR
0,34 EUR
+0,96 %
XDUS: Düsseldorf
Düsseldorf
IMI2US76.DUSB
EUR
26.01.2026 20:47
35,16 EUR
-0,07 EUR
-0,21 %
XHAM: Hamburg
Hamburg
IMI2US76.HAMB
EUR
26.01.2026 07:17
34,93 EUR
-0,31 EUR
-0,87 %
Company Profile for IMII-US T.B.1-3 EOD ETF
The investment objective of the Fund is to achieve the performance of the Bloomberg Barclays US Treasury 1-3 Year Index (the Reference Index) less fees, expenses and transaction costs
AI Analysis of IMII-US T.B.1-3 EOD
Click any analysis below to get instant AI insights from finAgent
Latest AI Analyses of IMII-US T.B.1-3 EOD
No AI threads available for this company yet.

Company Data

Name IMII-US T.B.1-3 EOD
Company Invesco US Treasury Bond 1-3 Year UCITS ETF
Primary Exchange XFRA XETRA
WKN A3E4ZY
ISIN IE00BF2FNJ76
Asset Class ETF
Sector Financial Services
Industry Asset Management - Bonds
Country Ireland
Currency EUR
Employees -
IPO Date 2022-02-04

Ticker Symbols

Name Symbol
Düsseldorf IMI2US76.DUSB
Frankfurt T3RE.F
Hamburg IMI2US76.HAMB
Quotrix IMI2US76.DUSD
XETRA T3RE.DE
More Shares
Investors who hold IMII-US T.B.1-3 EOD also have the following shares in their portfolio:
Fujian Yongfu Power Engineering Co.,Ltd.
Fujian Yongfu Power Engineering Co.,Ltd. Share
THC Farmaceuticals, Inc.
THC Farmaceuticals, Inc. Share
The financial platform MoneyPeak tracks and analyzes investments and portfolios. From securities portfolios to crypto purchases.
Useful, simple, and free. Stocks, ETFs, ETCs, ETNs, indices, funds, bonds, certificates, currencies, options, rights issue.
Imprint Data Protection Blog Community Feedback Changelog
Im App Store herunterladen Bei Google Play herunterladen
All rights reserved © LCP GmbH 2026